Dr. Jethro Ekuta Joins BP Logix Life Sciences Strategic Advisory Board
'I believe BP Logix is uniquely positioned to help life sciences organizations streamline compliance, reduce risk and move faster without compromising integrity."
Share
Dr. Ekuta is the Chair of the Board of Directors for the Regulatory Affairs Professionals Society (RAPS) and currently serves as Chief Regulatory & Safety Officer at Ascendis Pharma.
With over 30 years of experience in regulatory affairs and pharmacovigilance, Dr. Ekuta brings a deep understanding of global compliance, regulatory strategy and innovation in drug development. He has held senior leadership roles at organizations including Ascendis Pharma, Alexion (AstraZeneca Rare Disease), Horizon Therapeutics (Amgen), Johnson & Johnson, Genzyme (Sanofi), Bristol-Myers Squibb, Pfizer and the U.S. Food and Drug Administration (FDA).
'We are honored to welcome Dr. Ekuta to our Life Sciences Strategic Advisory Board,' said Girish Pashilkar, CEO of BP Logix. 'His regulatory insight and leadership will be instrumental as we continue to expand our footprint in the life sciences sector and support teams navigating increasingly complex review and approval processes.'
'I've spent my career working to improve regulatory systems and processes within the pharmaceutical and biotech industries,' said Dr. Ekuta. 'I believe BP Logix is uniquely positioned to help life sciences organizations streamline compliance, reduce risk and move faster without compromising integrity. I'm excited to contribute to the company's mission and support its growth in this critical space.'
In his advisory role, Dr. Ekuta will provide strategic input across marketing, product, and customer engagement initiatives. His appointment is part of a broader effort by BP Logix to deepen its alignment with industry leaders and further tailor its solutions to the evolving needs of life sciences organizations.
About BP Logix
BP Logix helps medical affairs and regulatory teams at life sciences organizations streamline complex review and approval workflows. Its flagship solution, PubPro, simplifies the publication process, while the broader Approvia platform supports use cases such as MLR reviews, clearance systems, medical information requests and IIS evaluations. With a focus on configurability, compliance and speed, BP Logix empowers teams to reduce risk, improve collaboration and bring high-quality treatments to market faster.
To learn more about BP Logix and its work in life sciences, visit www.bplogix.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
27-06-2025
- Associated Press
Over $500M in Impact Investments Across 50+ Businesses
Based in Zug, Switzerland, Impact Investing Solutions is dedicated to fostering sustainable development through strategic impact investing. ZUG, SWITZERLAND, June 27, 2025 / / -- Impact Investing Solutions (IIS), a leader in impact investing, connects capital with sustainable change worldwide. IIS provide end-to-end solutions, from preparing projects for investment to guiding investors, having facilitated over $500 million in impact investments across 50+ businesses. Impact Investing Solutions helps bridge the gap between intention and scalable impact, focusing on solutions that benefit both people and the planet. IIS, believe investing should touch lives and transform futures. In Bali, IIS support the Plastic Angels project—a lifeline for children growing up surrounded by plastic waste. Through daily meals and education, this initiative offers not just nourishment and knowledge, but dignity, care, and the chance to dream beyond their circumstances. In Mexico, IIS work with a football academy that does more than teach kids how to score goals—it teaches them to live in harmony with nature. Through sport, they learn teamwork, respect, and sustainability, finding purpose and belonging far from the risks of the streets. In the Philippines, IIS partner with a courageous organization fighting the horrors of women trafficking. Together, also support safe havens and rehabilitation programs that help survivors heal, rebuild their lives, and rediscover their strength. Each of these stories is a testament to what's possible when purpose meets capital—when investments are made not only with vision, but with heart. 'IIS believe true innovation lies in aligning financial success with a positive footprint on the world,' says Sveta Banerjee, CEO of Impact Investing Solutions. 'IIS approach mitigates risks from climate change and social inequality, unlocking opportunities for sustainable growth and positive societal impact.' IIS Comprehensive Solutions IIS combines human expertise with cutting-edge technology: 1: Consulting (For Projects & Investors): Tailored guidance to make projects investor-ready and align investor capital with their values. 2: Mobilizing Capital for Good: Connecting changemakers with catalytic capital to scale solutions. 3: Educational Programs: Workshops and masterclasses to equip individuals with impact investing knowledge. 4: Swiss Impact TV Show: A weekly global talk show featuring thought leaders, reaching millions of viewers. 5: AI-Powered Impact Platform: IIS proprietary platform uses AI to precisely match impactful projects with the right investors, enabling smarter and more efficient decisions. 'IIS mission is clear: to accelerate the flow of capital to where it can do the most good,' adds Ben Banerjee, Co-Founder. 'By combining personalized consulting with powerful AI, global media outreach, and essential education, IIS transform good intentions into tangible, scalable impact. IIS is excited to partner with those ready to create a legacy of positive change. 'About Impact Investing Solutions (IIS) Based in Zug, Switzerland, IIS is dedicated to fostering sustainable development through strategic impact investing. IIS empower investors and projects to achieve both financial success and profound social and environmental impact worldwide. M Ahsan Aslam Impact Investing Solutions [email protected] Visit us on social media: LinkedIn Bluesky Instagram Facebook YouTube TikTok X Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Business Wire
26-06-2025
- Business Wire
IIS Announces RGA Leaders of Tomorrow Class of 2025, Set to Feature Participants at the Global Insurance Forum
NEW YORK--(BUSINESS WIRE)--The International Insurance Society (IIS) is proud to announce the RGA Leaders of Tomorrow Class of 2025, a talented, global group of emerging insurance executives. Select participants will share their insights at the 61 st IIS Global Insurance Forum, convening Oct. 26-27, 2025, at the Swiss Re Centre for Global Dialogue. 'The RGA Leaders of Tomorrow program is a powerful catalyst for shaping the insurance industry's most promising talent into impactful leaders." (RGA), a global leader in life and health reinsurance, continues its long-standing role as Gold Partner and sponsor of the Leaders of Tomorrow. The program fosters leadership development among rising professionals with demonstrated potential, pairing them with senior executive mentors to address pressing strategic issues, promote cross-functional collaboration, and build global peer networks. 'The RGA Leaders of Tomorrow program is a powerful catalyst for shaping the insurance industry's most promising talent into impactful leaders,' said Josh Landau, President of the International Insurance Society (IIS). 'Our enduring partnership with RGA reflects a profound, shared commitment to cultivating the next generation of leadership. More than a celebration of mentorship, this initiative represents a strategic investment in the long-term sustainability, innovation, and resilience of our industry.' "For more than a decade, RGA's sponsorship of the Leaders of Tomorrow Program has demonstrated our unwavering commitment to nurturing exceptional talent in the insurance sector," stated Tony Cheng, President and Chief Executive Officer of RGA. 'Through personalized mentorship, peer networking, and exposure to industry insights, we equip emerging leaders with the tools to improve their leadership abilities. We're empowering these promising professionals to not only navigate tomorrow's complex challenges but also guide others, driving innovation and success across the industry.' Within the program, each mentee conducts research and presents an original paper. Based on their research and paper, one outstanding program participant is recognized with the RGA Leaders of Tomorrow Award, and three mentees will be selected to join a signature panel discussion entitled 'Next Generation Leadership.' Beyond the RGA Leaders of Tomorrow, the 2025 Global Insurance Forum will explore the theme of 'Navigating the Future of Risk,' featuring insights from over 40 global executives and thought leaders. Topics include the following: Leading Through Change: The Future of Insurance in a Transforming World Harnessing the Power of AI and Data: Transforming the Future of Insurance Building Resilience in a World of Uncertainty: Insurance Strategies Amid Global Trade Shifts and Emerging Risks For more information on the Global Insurance Forum and to register, visit About International Insurance Society IIS is a non-profit organization that brings together insurance and risk management professionals from around the world. Insurance helps businesses thrive, communities grow, and people overcome hardship. The mission is simple: by providing education, recognizing excellence, and supporting career growth, the IIS works to foster a global community that can protect and empower society for generations to come. IIS is an affiliate of The Institutes. About The Institutes The Institutes are a global not-for-profit comprised of diverse affiliates that educate, elevate, and connect people in the essential disciplines of risk management and insurance. Through products and services offered by The Institutes' nearly 20 affiliated business units, people and organizations are empowered to help those in need with a focus on understanding, predicting, and preventing losses to create a more resilient world. About RGA Reinsurance Group of America, Incorporated (NYSE: RGA) is a global industry leader specializing in life and health reinsurance and financial solutions that help clients effectively manage risk and optimize capital. Founded in 1973, RGA is today one of the world's largest and most respected reinsurers and remains guided by a powerful purpose: to make financial protection accessible to all. As a global capabilities and solutions leader, RGA empowers partners through bold innovation, relentless execution, and dedicated client focus — all directed toward creating sustainable long-term value. RGA has approximately $4.0 trillion of life reinsurance in force and assets of $128.2 billion as of March 31, 2025. To learn more about RGA and its businesses, please visit or follow RGA on LinkedIn and Facebook. Investors can learn more at
Yahoo
24-06-2025
- Yahoo
Oppenheimer Hikes Ascendis Pharma Price Target on Strong Yorvipath Demand Outlook
Ascendis Pharma A/S (NASDAQ:ASND) is one of billionaire Stan Druckenmiller's top stock picks with huge upside potential. Oppenheimer maintained its Outperform rating on Ascendis Pharma A/S (NASDAQ:ASND) while increasing its price target from $215 to $224 on June 13. The change comes after a commissioned survey of 20 endocrinologists in the United States who treat hypoparathyroidism showed a high initial demand for the company's drug, Yorvipath. According to doctors, 20–30% of their hypoparathyroid patients are expected to be taking the medication within a year. According to the poll, 90% of physicians would recommend Yorvipath to maintain kidney function before renal impairment develops. This affinity is consistent with the prevalence of renal impairment among patients with hypoparathyroidism. The primary barriers to adoption, according to the majority of physicians, are access and reimbursement; however, Oppenheimer indicated that these worries 'may be more anticipation than reality.' Yorvipath's first full quarter in the United States was described by the firm as 'just the beginning of a launch that will outpace expectations.' Ascendis Pharma A/S (NASDAQ:ASND) is a biopharmaceutical company that develops and distributes novel treatments for unmet medical needs, especially in the fields of oncology and endocrinology. While we acknowledge the potential of ASND as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None.
